Our results revealed that there was a significant increase in miR 6807-5p concomitant with marked increase in SMAD4 and significant down regulation of SOX11, and AMOTL2 mRNA levels in the liver tissue of NASH group compared to NC or treated groups. The gene discussed is SMAD4; the disease is metabolic dysfunction-associated steatohepatitis.